QuantiFERON-TB reversion in children and adolescents with tuberculosis


Por: Rodríguez-Molino P, González Sánchez A, Noguera-Julian A, Soler-García a, Martínez Paz P, Méndez-Echevarría A, Baquero-Artigao F, González Muñoz M, Ruíz-Serrano MJ, Manuel Monsonis Cabedo, Sánchez León R, Saavedra-Lozano J, Santiago-García B and Sainz T

Publicada: 21 mar 2024 Ahead of Print: 21 mar 2024
Resumen:
We analyzed 136 children with tuberculosis disease or infection and a positive QuantiFERON-TB (QFT) assay, followed-up for a median of 21 months (0.4-11years). QFT reversed in 16.9% of cases, with significant decreases in TB1 (-1.72 vs. -0.03 IU/ml, p=0.001) and TB2 (-1.65 vs. -0.43 IU/ml, p=0.005) levels compared to non-reverters. We found a higher QFT reversion rate among children under 5 years (25.0% vs 11.9%, p=0.042), and those with TST induration <15mm (29% vs 13.3%, p=0.055). Our data reveal that, although QFT test remained positive in the majority of children, reversion occurred in 16% of cases in a progressive and stable pattern. Younger age and reduced TST induration were associated with QFT reversion.

Filiaciones:
Rodríguez-Molino P:
 General Pediatrics, Infectious and Tropical Diseases Department, Hospital La Paz, Madrid, Spain

 La Paz Research Institute (IdiPAZ), Madrid, Spain

 Universidad Autonoma de Madrid (UAM), Madrid, Spain

 Centro de Investigación Biomédica en Red en Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain

González Sánchez A:
 General Pediatrics, Hospital Puerta de Hierro, Madrid, Spain

Noguera-Julian A:
 Malalties Infeccioses i Resposta Inflamatòria Sistèmica en Pediatria, Servei de Malalties Infeccioses Patologia Importada, Institut de Recerca Pediàtrica Sant Joan de Déu, Barcelona, Spain

 Departament de Cirurgia i Especialitats Medicoquirúrgiques, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain

 Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública, Instituto de Salud Carlos III, Madrid, Spain

 Red de Investigación Translacional en Infectología Pediátrica (RITIP), Madrid, Spain

Soler-García a:
 Malalties Infeccioses i Resposta Inflamatòria Sistèmica en Pediatria, Servei de Malalties Infeccioses Patologia Importada, Institut de Recerca Pediàtrica Sant Joan de Déu, Barcelona, Spain

Martínez Paz P:
 General Pediatrics, Infectious and Tropical Diseases Department, Hospital La Paz, Madrid, Spain

Méndez-Echevarría A:
 General Pediatrics, Infectious and Tropical Diseases Department, Hospital La Paz, Madrid, Spain

 La Paz Research Institute (IdiPAZ), Madrid, Spain

 Universidad Autonoma de Madrid (UAM), Madrid, Spain

 Centro de Investigación Biomédica en Red en Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain

Baquero-Artigao F:
 General Pediatrics, Infectious and Tropical Diseases Department, Hospital La Paz, Madrid, Spain

 La Paz Research Institute (IdiPAZ), Madrid, Spain

 Universidad Autonoma de Madrid (UAM), Madrid, Spain

 Centro de Investigación Biomédica en Red en Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain

González Muñoz M:
 Department of Immunology, Hospital La Paz, Madrid, Spain

Ruíz-Serrano MJ:
 Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañon, Madrid, Spain

 Instituto de Investigación Sanitaria Gregorio Marañón (IISGM), Madrid, Spain

 Centro de Investigación Biomédica en Red (CIBER) de Enfermedades Respiratorias - CIBERES, Madrid, Spain

Manuel Monsonis Cabedo:
 Servei de Microbiologia, Hospital Sant Joan de Déu, Barcelona, Spain

Sánchez León R:
 General Pediatrics, Infectious and Tropical Diseases Department, Hospital La Paz, Madrid, Spain

 Centro de Investigación Biomédica en Red en Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain

Saavedra-Lozano J:
 Infectious Diseases Department, General Pediatrics, Hospital Gregorio Marañón, Madrid, Spain

Santiago-García B:
 Centro de Investigación Biomédica en Red en Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain

 Instituto de Investigación Sanitaria Gregorio Marañón (IISGM), Madrid, Spain

 Infectious Diseases Department, General Pediatrics, Hospital Gregorio Marañón, Madrid, Spain

Sainz T:
 General Pediatrics, Infectious and Tropical Diseases Department, Hospital La Paz, Madrid, Spain

 La Paz Research Institute (IdiPAZ), Madrid, Spain

 Universidad Autonoma de Madrid (UAM), Madrid, Spain

 Centro de Investigación Biomédica en Red en Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain

 Red de Investigación Translacional en Infectología Pediátrica (RITIP), Madrid, Spain
ISSN: 16643224





Frontiers in Immunology
Editorial
FRONTIERS MEDIA SA, AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE CH-1015, SWITZERLAND, Suiza
Tipo de documento: Article
Volumen: 15 Número:
Páginas: 1310472-1310472
WOS Id: 001196266100001
ID de PubMed: 38576621
imagen Green Submitted, gold

MÉTRICAS